Erythropoietin is used for: Anemia associated with Chronic Renal Failure; including patients on dialysis (ESRD) and patients not on dialysis; Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy; Anemic patients (hemoglobin > 10 to < 13 g/dL) scheduled to undergo elective; noncardiac; nonvascular surgery to reduce the need for allogeneic blood transfusions; Anemia related to therapy with zidovudine in HIV-infected patients.
Recorded in the NepalDoc medicine catalog for Erythropoietin.
PROCRIT is an erythropoiesis-stimulating agent (ESA) indicated for: Treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis. Zidovudine in patients with Human Immunodeficiency Virus (HIV) infection.
From the U.S. FDA-approved label for Erythropoietin. Full label: DailyMed.
PROCRIT is an erythropoiesis-stimulating agent (ESA) indicated for: Treatment of anemia due to Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis. Zidovudine in patients with Human Immunodeficiency Virus (HIV) infection. The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy. Reduction of allogeneic red blood cell (RBC) transfusions in patients undergoing elective, noncardiac, nonvascular surgery.
From the U.S. FDA-approved label for Erythropoietin. Full label: DailyMed.
Evaluate iron status before and during treatment and maintain iron repletion. Correct or exclude other causes of anemia before initiating treatment. In pregnant women, lactating women, neonates, infants: Use only single-dose vials.
Directions from the U.S. FDA-approved label for Erythropoietin — your doctor or pharmacist may advise differently.
PROCRIT is contraindicated in patients with: Uncontrolled hypertension Pure red cell aplasia (PRCA) that begins after treatment with PROCRIT or other erythropoietin protein drugs Serious allergic reactions to PROCRIT PROCRIT from multiple-dose vials contains benzyl alcohol and is contraindicated in: Neonates, infants, pregnant women, and lactating women.
Excerpt from the U.S. FDA-approved label for Erythropoietin. Talk to a pharmacist or doctor before use.
Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism: Using ESAs to target a hemoglobin level of greater than 11 g/dL increases the risk of serious adverse cardiovascular reactions and has not been shown to provide additional benefit ( 5.1 and 14.1 ). Use caution in patients with coexistent cardiovascular disease and stroke. Increased Mortality and/or Increased Risk of Tumor Progression or Recurrence in Patients with Cancer. Hypertension: Control hypertension prior to initiating and during treatment with PROCRIT. Seizures: PROCRIT increases the risk for seizures in patients with CKD.
Warnings and precautions excerpt from the U.S. FDA-approved label for Erythropoietin — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are discussed in greater detail in other sections of the label: Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism Increased Mortality and/or Increased Risk of Tumor Progression or Recurrence in Patients with Cancer Hypertension Seizures PRCA Serious Allergic Reactions Severe Cutaneous Reactions Patients with CKD: Adverse reactions in ≥ 5% of PROCRIT-treated…
Excerpt from the U.S. FDA-approved label for Erythropoietin — not a complete list. Talk to a pharmacist or doctor about side effects.
7 brands · 3 makers in the NepalDoc catalog — see the full Erythropoietin guide →
Store at 36°F to 46°F (2°C to 8°C). Do not freeze. Do not shake. Do not use PROCRIT that has been shaken or frozen. Store PROCRIT vials in the original carton until use to protect from light.
Storage information from the U.S. FDA-approved label for Erythropoietin.
What is Wepox?
Wepox 4000IU Injection is a Erythropoietin medicine made by Wockhardt Ltd. It comes as 4000IU Injection.
What is Wepox used for?
Erythropoietin is used for Anemia associated with Chronic Renal Failure, including patients on dialysis (ESRD) and patients not on dialysis, Anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy, Anemic patients (hemoglobin > 10 to < 13 g/dL) scheduled to undergo elective, noncardiac, nonvascular surgery to reduce the need for allogeneic blood transfusions, Anemia related to therapy with zidovudine in HIV-infected patients.
What is the generic name of Wepox?
The generic name of Wepox is Erythropoietin.
Which brands of Erythropoietin are available in Nepal?
7 brands of Erythropoietin are listed in the NepalDoc catalog, from 3 makers — including Epofit 2000IU Tablet, Epofit 4000IU Tablet, Epofit 6000I.U. Tablet, Shanpoietin 2000IU Injection, Shanpoietin 4000IU Injection, Wepox 2000IU Injection.
What are the side effects of Erythropoietin?
The following serious adverse reactions are discussed in greater detail in other sections of the label: Increased Mortality, Myocardial Infarction, Stroke, and Thromboembolism Increased Mortality and/or Increased Risk of Tumor Progression or Recurrence in Patients with Cancer Hypertension Seizures PRCA Serious Allergic Reactions Severe Cutaneous Reactions Patients with CKD: Adverse reactions in ≥ 5% of PROCRIT-treated…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
